Ipcor - Irish Prostate Cancer Outcomes Research - IPCOR is developing a registry

Please tell us about how prostate cancer and/or your treatment is affecting you by completing the IPCOR questionnaires Log in to Questionnaires

IPCOR is developing a registry of men who have been newly diagnosed with prostate cancer Developing a registry

Ipcor - Irish Prostate Cancer Outcomes Research - IPCOR will collect clinical

IPCOR is funded by the Movember Foundation in partnership with the Irish Cancer Society IPCOR is funded by

Ipcor - Irish Prostate Cancer Outcomes Research - IPCOR will collect information

IPCOR will collect clinical data on men who have been newly diagnosed with prostate cancer Collecting clinical data

Ipcor - Irish Prostate Cancer Outcomes Research - IPCOR will provide evidence-based

IPCOR will collect information from men about their quality of life Collecting quality of life data

Ipcor - Irish Prostate Cancer Outcomes Research - slide5

IPCOR aims to improve prostate cancer care and maximise men's quality of life Improving prostate cancer care

About IPCOR

Background

The Irish Prostate Cancer Outcomes Research is establishing a nationwide prostate cancer registry which captures high-quality information from newly diagnosed prostate cancer patients in the Republic of Ireland.

Our Goals

Aims

Our main objective is to collect detailed clinical and quality of life data on Irish men’s prostate cancer journey to better inform future care delivery, knowledge of the disease and best use of health care innovations and resources.

Research & Publications

Research

In order to improve prostate cancer care, IPCOR will publish reports with a high level of clinical information and sophisticated data analysis. These reports will be published annually and delivered to service providers and decision makers in healthcare.

Welcome to IPCOR, the Irish Prostate Cancer Outcomes Research

IPCOR is collecting clinical data and quality of life information from men who have been newly diagnosed with prostate cancer in Ireland and is developing, for the first time, a national prostate cancer registry. IPCOR publishes annual reports on the outcomes of prostate cancer treatment and care. These reports provide evidence-based data to doctors, hospitals and policy makers to inform future healthcare decisions that affect prostate cancer care.

The ultimate goal of IPCOR is to enhance prostate cancer care, improve patient experiences and maximise quality of life for men diagnosed with prostate cancer in Ireland.

The Irish Prostate Cancer Outcomes Research began in February 2014. The Irish Cancer Society and Movember are supporting this project with funding of €1.75 million over 5 years. This research is being carried out by a collaborative partnership involving the National Cancer Registry Ireland, the HRB Clinical Research Facility in Galway, the National Cancer Control Program and the nation’s major academic institutions represented by Molecular Medicine Ireland.

IPCOR is developing a Registry of men who have been newly diagnosed with Prostate Cancer in Ireland